Vibegron
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Vibegron is used to treat overactive urinary bladder, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 23, 2020. In 2024, Medicare Part D spent $945 million on Vibegron across 1.4 million claims for 320,000 beneficiaries.
Vibegron is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $16.46 to $16.46 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$16.46 – $16.46
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sumitomo Pharma America, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
beta3-Adrenergic Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing VIBEGRON
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GEMTESA 75 MG TABLET | $16.4597 per EA | +0.01% |
GEMTESA 75 MG TABLET | $16.4597 per EA | +0.01% |
Frequently Asked Questions
What is Vibegron used to treat?
Vibegron is used to treat overactive urinary bladder, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Vibegron?
In 2024, Medicare Part D spent $945 million on Vibegron across 1.4 million claims for 320,000 beneficiaries.
How many Vibegron products are on the market?
The Vibegron drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Vibegron?
NADAC reference prices for Vibegron range from $16.4597 to $16.4597 per EA.
Which manufacturers make Vibegron?
1 manufacturer lists Vibegron in NADAC. Ranked by number of NDCs, the largest are Sumitomo Pharma America, Inc. (2).
How has the price of Vibegron changed recently?
Over the past 7 days, 2 Vibegron NDCs rose and 0 fell, with a market-wide average change of +0.0%.